Author: MarketBeat

Robeco Institutional Asset Management B.V. acquired a new position in Vir Biotechnology, Inc. (NASDAQ:VIR - Get Rating) in the third quarter, according to the company in its most recent filing with the SEC. The firm acquired 32,911 shares of the company's stock, valued at approximately $635,000. Ot

Pier Capital LLC lowered its stake in Cerus Co. (NASDAQ:CERS - Get Rating) by 22.0% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,351,218 shares of the biotechnology company's stock after selling 380,161

Marathon Capital Management purchased a new stake in shares of iShares Biotechnology ETF (NASDAQ:IBB - Get Rating) in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm purchased 4,015 shares of the financial services prov

WINTON GROUP Ltd boosted its stake in Vir Biotechnology, Inc. (NASDAQ:VIR - Get Rating) by 20.7% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 57,642 shares of the company's stock after acquiring an additio